MURINE MODEL TO PREDICT VIRAL REBOUND IN HIV+ ALLOTRANSPLANTED SUBJECTS
Allogeneic stem cell transplantation (SCT) in HIV-infected subjects with hematological malignancies considerably reduces the viral reservoir. However, because antiretroviral treatment (cART) is maintained in these patients, it is difficult to infer the dynamics of viral rebound if cART is withdrawn. Herein, we explore the mice viral outgrowth approach (mVOA) as a potential tool to predict…